USPTO serial 79291398
ZIONEXA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 2, 2021
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ZIONEXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marina Dostal
Marina Dostal GE Precision Healthcare LLC3000 N Grandview BoulevardIP Department (Mail Code W-436)Waukesha, WI 53188Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Radiopharmaceuticals for treating oncological diseases; in-vivo diagnostic markers used for detection and monitoring of oncological therapy; pharmaceutical preparations for human and veterinary use for treating oncological diseases; biological preparations for medical use for treating cancer; chemical preparations for medical use for treating cancer; food supplements and nutritional supplements for medical use; dietetic food and beverages for medical and pharmaceutical use; homeopathic supplements; plant therapy compositions, namely, medicinal teas; sanitary tampons for medical purposes; medicated bath preparations; dietetic beverages for medical use; chemical diagnostic reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medicated douching preparations; medical plasters; medical dressings; surgical and medical dressings | ACTIVE | — |
| 010 | Medical devices for diagnostic use for administering contrast media; medical diagnostic instruments for detecting cancer; surgical apparatus and instruments; medical instruments for collection of human body fluids; kits primarily comprised of surgical instruments; containers for medical cancer samples; medicine administering tubes for surgical applications; container holders specifically adapted for holding medical samples; medicine administering tubes for medical applications; syringes for medical use; syringe needles for medical use; containers especially adapted for depositing medical syringes | ACTIVE | — |
| 041 | Training services in the fields of healthcare, pharmaceuticals, medical research, pharmaceutical, and medicine development; publication of books and texts other than advertising texts in the pharmaceutical, medical and health fields; arranging and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical, medical and health fields | ACTIVE | — |
| 042 | Development of pharmaceutical products; pharmaceutical research and development; testing in the form of quality control for others of pharmaceutical products; carrying out clinical trials for pharmaceutical products for others; scientific research regarding medicine; computer bio-informatic system, chemical and biological analysis; research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological and bio-informatic research services in the field of chemical, biological and pharmaceutical products; software design and development in the field of pharmaceutical, health and medical research; Providing medical and scientific research information in the field of pharmaceutical products and clinical trials; research on chemical reagents for medical use, namely, biomarkers; design of databases in the field of pharmaceutical research and development, medicine, genetics and clinical trials | ACTIVE | — |
| 044 | Dispensing of pharmaceuticals services; pharmaceutical advice; medical services; medical information services; providing medical information; information services on the treatment of diseases via an awareness program; providing information with respect to pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GE Healthcare Limited
- Other trademarks owned by ZIONEXA
- Other trademarks owned by ZIONEXA
- Other trademarks owned by ZIONEXA
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ZIONEXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 23, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 31, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 11, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 30, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 30, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 30, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 30, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 30, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 28, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 3, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 3, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 2, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 15, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 25, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |